Completed OBSERVATIONAL NCT05313984

OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation. (OptiLUTS)

Optimization of Therapy Resistant LUTS (OptiLUTS) Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation: a Prospective Single Centre Study.

Sponsor: Medtronic

Conditions Dysfunctional Voiding Fecal Incontinence Fowler Syndrome Overactive Bladder Syndrome Urinary Retention

Interventions Sacral neuromodulation

Updated 4 times since 2022 Last updated: Sep 5, 2024 Started: Mar 1, 2018 Primary completion: Dec 1, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Dysfunctional Voiding and Fecal Incontinence and is currently completed. Medtronic leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Oct 2024 — Present [monthly]

Completed
Sep 2024 — Oct 2024 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2022 — Jul 2024 [monthly]

Completed

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
University Hospital, Ghent

Data source: University Hospital, Ghent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ghent, Belgium